172 related articles for article (PubMed ID: 24030433)
21. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemistry study of human vestibular nerve schwannoma differentiation.
Hung G; Colton J; Fisher L; Oppenheimer M; Faudoa R; Slattery W; Linthicum F
Glia; 2002 Jun; 38(4):363-70. PubMed ID: 12007148
[TBL] [Abstract][Full Text] [Related]
23. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
[TBL] [Abstract][Full Text] [Related]
24. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E32-E34. PubMed ID: 29309686
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity on chromosome 22 in sporadic schwannoma and its relation to the proliferation of tumor cells.
Bian LG; Sun QF; Tirakotai W; Zhao WG; Shen JK; Luo QZ; Bertalanffy H
Chin Med J (Engl); 2005 Sep; 118(18):1517-24. PubMed ID: 16232328
[TBL] [Abstract][Full Text] [Related]
26. Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas.
Koutsimpelas D; Ruerup G; Mann WJ; Brieger J
ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):33-7. PubMed ID: 22249120
[TBL] [Abstract][Full Text] [Related]
27. Constitutional LZTR1 mutation presenting with a unilateral vestibular schwannoma in a teenager.
Gripp KW; Baker L; Kandula V; Piatt J; Walter A; Chen Z; Messiaen L
Clin Genet; 2017 Nov; 92(5):540-543. PubMed ID: 28295212
[TBL] [Abstract][Full Text] [Related]
28. Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas.
de Vries M; Bruijn IB; Cleton-Jansen AM; Malessy MJ; van der Mey AG; Hogendoorn PC
Virchows Arch; 2013 Feb; 462(2):211-7. PubMed ID: 23224067
[TBL] [Abstract][Full Text] [Related]
29. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
[TBL] [Abstract][Full Text] [Related]
30. Deregulated genes in sporadic vestibular schwannomas.
Cayé-Thomasen P; Borup R; Stangerup SE; Thomsen J; Nielsen FC
Otol Neurotol; 2010 Feb; 31(2):256-66. PubMed ID: 19816230
[TBL] [Abstract][Full Text] [Related]
31. A Bilateral Vestibular Schwannoma is Not Always Related to Neurofibromatosis Type 2.
Abeshi A; Ferri GG
J Int Adv Otol; 2023 Jun; 19(3):263-265. PubMed ID: 37272647
[TBL] [Abstract][Full Text] [Related]
32. Molecular biology of familial and sporadic vestibular schwannomas: implications for novel therapeutics.
Sughrue ME; Yeung AH; Rutkowski MJ; Cheung SW; Parsa AT
J Neurosurg; 2011 Feb; 114(2):359-66. PubMed ID: 19943731
[TBL] [Abstract][Full Text] [Related]
33. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.
Gehlhausen JR; Park SJ; Hickox AE; Shew M; Staser K; Rhodes SD; Menon K; Lajiness JD; Mwanthi M; Yang X; Yuan J; Territo P; Hutchins G; Nalepa G; Yang FC; Conway SJ; Heinz MG; Stemmer-Rachamimov A; Yates CW; Wade Clapp D
Hum Mol Genet; 2015 Jan; 24(1):1-8. PubMed ID: 25113746
[TBL] [Abstract][Full Text] [Related]
34. Updates on Tumor Biology in Vestibular Schwannoma.
Nourbakhsh A; Dinh CT
Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611
[TBL] [Abstract][Full Text] [Related]
35. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
Sainz J; Huynh DP; Figueroa K; Ragge NK; Baser ME; Pulst SM
Hum Mol Genet; 1994 Jun; 3(6):885-91. PubMed ID: 7951231
[TBL] [Abstract][Full Text] [Related]
36. A non-NF2 case of schwannomas of vestibular and trigeminal nerves with different genetic alterations of NF2 gene: case report.
Kambe A; Kamitani H; Watanabe T; Oka A; Inagaki H; Ishii T; Ueki K
Surg Neurol; 2005 Jan; 63(1):62-4; discussion 64-5. PubMed ID: 15639530
[TBL] [Abstract][Full Text] [Related]
37. Next Generation Sequencing of Sporadic Vestibular Schwannoma: Necessity of Biallelic NF2 Inactivation and Implications of Accessory Non-NF2 Variants.
Carlson ML; Smadbeck JB; Link MJ; Klee EW; Vasmatzis G; Schimmenti LA
Otol Neurotol; 2018 Oct; 39(9):e860-e871. PubMed ID: 30106846
[TBL] [Abstract][Full Text] [Related]
38. Clinical risk factor analysis of bilateral vestibular schwannoma's growth pattern inconsistency in individual NF2 patients.
Li P; Li S; Wang Y; Zhao F; Wang Z; Wang X; Wang B; Yang Z; Liu P
Clin Neurol Neurosurg; 2021 Jan; 200():106365. PubMed ID: 33243701
[TBL] [Abstract][Full Text] [Related]
39. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
[TBL] [Abstract][Full Text] [Related]
40. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas.
Van Gompel JJ; Agazzi S; Carlson ML; Adewumi DA; Hadjipanayis CG; Uhm JH; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E52-E54. PubMed ID: 29309638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
